1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Nanobiotechnology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Nanomedicine 1.2.3 Nano Medical Devices 1.2.4 Nano Diagnosis 1.2.5 Other 1.3 Market by Application 1.3.1 Global Nanobiotechnology Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Anticancer 1.3.3 CNS Product 1.3.4 Anti-infective 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Nanobiotechnology Market Perspective (2016-2027) 2.2 Nanobiotechnology Growth Trends by Regions 2.2.1 Nanobiotechnology Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Nanobiotechnology Historic Market Share by Regions (2016-2021) 2.2.3 Nanobiotechnology Forecasted Market Size by Regions (2022-2027) 2.3 Nanobiotechnology Industry Dynamic 2.3.1 Nanobiotechnology Market Trends 2.3.2 Nanobiotechnology Market Drivers 2.3.3 Nanobiotechnology Market Challenges 2.3.4 Nanobiotechnology Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Nanobiotechnology Players by Revenue 3.1.1 Global Top Nanobiotechnology Players by Revenue (2016-2021) 3.1.2 Global Nanobiotechnology Revenue Market Share by Players (2016-2021) 3.2 Global Nanobiotechnology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Nanobiotechnology Revenue 3.4 Global Nanobiotechnology Market Concentration Ratio 3.4.1 Global Nanobiotechnology Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Nanobiotechnology Revenue in 2020 3.5 Nanobiotechnology Key Players Head office and Area Served 3.6 Key Players Nanobiotechnology Product Solution and Service 3.7 Date of Enter into Nanobiotechnology Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Nanobiotechnology Breakdown Data by Type 4.1 Global Nanobiotechnology Historic Market Size by Type (2016-2021) 4.2 Global Nanobiotechnology Forecasted Market Size by Type (2022-2027) 5 Nanobiotechnology Breakdown Data by Application 5.1 Global Nanobiotechnology Historic Market Size by Application (2016-2021) 5.2 Global Nanobiotechnology Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Nanobiotechnology Market Size (2016-2027) 6.2 North America Nanobiotechnology Market Size by Type 6.2.1 North America Nanobiotechnology Market Size by Type (2016-2021) 6.2.2 North America Nanobiotechnology Market Size by Type (2022-2027) 6.2.3 North America Nanobiotechnology Market Size by Type (2016-2027) 6.3 North America Nanobiotechnology Market Size by Application 6.3.1 North America Nanobiotechnology Market Size by Application (2016-2021) 6.3.2 North America Nanobiotechnology Market Size by Application (2022-2027) 6.3.3 North America Nanobiotechnology Market Size by Application (2016-2027) 6.4 North America Nanobiotechnology Market Size by Country 6.4.1 North America Nanobiotechnology Market Size by Country (2016-2021) 6.4.2 North America Nanobiotechnology Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Nanobiotechnology Market Size (2016-2027) 7.2 Europe Nanobiotechnology Market Size by Type 7.2.1 Europe Nanobiotechnology Market Size by Type (2016-2021) 7.2.2 Europe Nanobiotechnology Market Size by Type (2022-2027) 7.2.3 Europe Nanobiotechnology Market Size by Type (2016-2027) 7.3 Europe Nanobiotechnology Market Size by Application 7.3.1 Europe Nanobiotechnology Market Size by Application (2016-2021) 7.3.2 Europe Nanobiotechnology Market Size by Application (2022-2027) 7.3.3 Europe Nanobiotechnology Market Size by Application (2016-2027) 7.4 Europe Nanobiotechnology Market Size by Country 7.4.1 Europe Nanobiotechnology Market Size by Country (2016-2021) 7.4.2 Europe Nanobiotechnology Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Nanobiotechnology Market Size (2016-2027) 8.2 Asia-Pacific Nanobiotechnology Market Size by Type 8.2.1 Asia-Pacific Nanobiotechnology Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Nanobiotechnology Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Nanobiotechnology Market Size by Type (2016-2027) 8.3 Asia-Pacific Nanobiotechnology Market Size by Application 8.3.1 Asia-Pacific Nanobiotechnology Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Nanobiotechnology Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Nanobiotechnology Market Size by Application (2016-2027) 8.4 Asia-Pacific Nanobiotechnology Market Size by Region 8.4.1 Asia-Pacific Nanobiotechnology Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Nanobiotechnology Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Nanobiotechnology Market Size (2016-2027) 9.2 Latin America Nanobiotechnology Market Size by Type 9.2.1 Latin America Nanobiotechnology Market Size by Type (2016-2021) 9.2.2 Latin America Nanobiotechnology Market Size by Type (2022-2027) 9.2.3 Latin America Nanobiotechnology Market Size by Type (2016-2027) 9.3 Latin America Nanobiotechnology Market Size by Application 9.3.1 Latin America Nanobiotechnology Market Size by Application (2016-2021) 9.3.2 Latin America Nanobiotechnology Market Size by Application (2022-2027) 9.3.3 Latin America Nanobiotechnology Market Size by Application (2016-2027) 9.4 Latin America Nanobiotechnology Market Size by Country 9.4.1 Latin America Nanobiotechnology Market Size by Country (2016-2021) 9.4.2 Latin America Nanobiotechnology Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Nanobiotechnology Market Size (2016-2027) 10.2 Middle East & Africa Nanobiotechnology Market Size by Type 10.2.1 Middle East & Africa Nanobiotechnology Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Nanobiotechnology Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Nanobiotechnology Market Size by Type (2016-2027) 10.3 Middle East & Africa Nanobiotechnology Market Size by Application 10.3.1 Middle East & Africa Nanobiotechnology Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Nanobiotechnology Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Nanobiotechnology Market Size by Application (2016-2027) 10.4 Middle East & Africa Nanobiotechnology Market Size by Country 10.4.1 Middle East & Africa Nanobiotechnology Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Nanobiotechnology Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Amgen 11.1.1 Amgen Company Details 11.1.2 Amgen Business Overview 11.1.3 Amgen Nanobiotechnology Introduction 11.1.4 Amgen Revenue in Nanobiotechnology Business (2016-2021) 11.1.5 Amgen Recent Development 11.2 Teva Pharmaceuticals 11.2.1 Teva Pharmaceuticals Company Details 11.2.2 Teva Pharmaceuticals Business Overview 11.2.3 Teva Pharmaceuticals Nanobiotechnology Introduction 11.2.4 Teva Pharmaceuticals Revenue in Nanobiotechnology Business (2016-2021) 11.2.5 Teva Pharmaceuticals Recent Development 11.3 Abbott 11.3.1 Abbott Company Details 11.3.2 Abbott Business Overview 11.3.3 Abbott Nanobiotechnology Introduction 11.3.4 Abbott Revenue in Nanobiotechnology Business (2016-2021) 11.3.5 Abbott Recent Development 11.4 UCB 11.4.1 UCB Company Details 11.4.2 UCB Business Overview 11.4.3 UCB Nanobiotechnology Introduction 11.4.4 UCB Revenue in Nanobiotechnology Business (2016-2021) 11.4.5 UCB Recent Development 11.5 Roche 11.5.1 Roche Company Details 11.5.2 Roche Business Overview 11.5.3 Roche Nanobiotechnology Introduction 11.5.4 Roche Revenue in Nanobiotechnology Business (2016-2021) 11.5.5 Roche Recent Development 11.6 Celgene 11.6.1 Celgene Company Details 11.6.2 Celgene Business Overview 11.6.3 Celgene Nanobiotechnology Introduction 11.6.4 Celgene Revenue in Nanobiotechnology Business (2016-2021) 11.6.5 Celgene Recent Development 11.7 Sanofi 11.7.1 Sanofi Company Details 11.7.2 Sanofi Business Overview 11.7.3 Sanofi Nanobiotechnology Introduction 11.7.4 Sanofi Revenue in Nanobiotechnology Business (2016-2021) 11.7.5 Sanofi Recent Development 11.8 Merck & Co 11.8.1 Merck & Co Company Details 11.8.2 Merck & Co Business Overview 11.8.3 Merck & Co Nanobiotechnology Introduction 11.8.4 Merck & Co Revenue in Nanobiotechnology Business (2016-2021) 11.8.5 Merck & Co Recent Development 11.9 Biogen 11.9.1 Biogen Company Details 11.9.2 Biogen Business Overview 11.9.3 Biogen Nanobiotechnology Introduction 11.9.4 Biogen Revenue in Nanobiotechnology Business (2016-2021) 11.9.5 Biogen Recent Development 11.10 Stryker 11.10.1 Stryker Company Details 11.10.2 Stryker Business Overview 11.10.3 Stryker Nanobiotechnology Introduction 11.10.4 Stryker Revenue in Nanobiotechnology Business (2016-2021) 11.10.5 Stryker Recent Development 11.11 Gilead Sciences 11.11.1 Gilead Sciences Company Details 11.11.2 Gilead Sciences Business Overview 11.11.3 Gilead Sciences Nanobiotechnology Introduction 11.11.4 Gilead Sciences Revenue in Nanobiotechnology Business (2016-2021) 11.11.5 Gilead Sciences Recent Development 11.12 Pfizer 11.12.1 Pfizer Company Details 11.12.2 Pfizer Business Overview 11.12.3 Pfizer Nanobiotechnology Introduction 11.12.4 Pfizer Revenue in Nanobiotechnology Business (2016-2021) 11.12.5 Pfizer Recent Development 11.13 3M Company 11.13.1 3M Company Company Details 11.13.2 3M Company Business Overview 11.13.3 3M Company Nanobiotechnology Introduction 11.13.4 3M Company Revenue in Nanobiotechnology Business (2016-2021) 11.13.5 3M Company Recent Development 11.14 Johnson & Johnson 11.14.1 Johnson & Johnson Company Details 11.14.2 Johnson & Johnson Business Overview 11.14.3 Johnson & Johnson Nanobiotechnology Introduction 11.14.4 Johnson & Johnson Revenue in Nanobiotechnology Business (2016-2021) 11.14.5 Johnson & Johnson Recent Development 11.15 Smith & Nephew 11.15.1 Smith & Nephew Company Details 11.15.2 Smith & Nephew Business Overview 11.15.3 Smith & Nephew Nanobiotechnology Introduction 11.15.4 Smith & Nephew Revenue in Nanobiotechnology Business (2016-2021) 11.15.5 Smith & Nephew Recent Development 11.16 Leadiant Biosciences 11.16.1 Leadiant Biosciences Company Details 11.16.2 Leadiant Biosciences Business Overview 11.16.3 Leadiant Biosciences Nanobiotechnology Introduction 11.16.4 Leadiant Biosciences Revenue in Nanobiotechnology Business (2016-2021) 11.16.5 Leadiant Biosciences Recent Development 11.17 Kyowa Hakko Kirin 11.17.1 Kyowa Hakko Kirin Company Details 11.17.2 Kyowa Hakko Kirin Business Overview 11.17.3 Kyowa Hakko Kirin Nanobiotechnology Introduction 11.17.4 Kyowa Hakko Kirin Revenue in Nanobiotechnology Business (2016-2021) 11.17.5 Kyowa Hakko Kirin Recent Development 11.18 Shire 11.18.1 Shire Company Details 11.18.2 Shire Business Overview 11.18.3 Shire Nanobiotechnology Introduction 11.18.4 Shire Revenue in Nanobiotechnology Business (2016-2021) 11.18.5 Shire Recent Development 11.19 Ipsen 11.19.1 Ipsen Company Details 11.19.2 Ipsen Business Overview 11.19.3 Ipsen Nanobiotechnology Introduction 11.19.4 Ipsen Revenue in Nanobiotechnology Business (2016-2021) 11.19.5 Ipsen Recent Development 11.20 Endo International 11.20.1 Endo International Company Details 11.20.2 Endo International Business Overview 11.20.3 Endo International Nanobiotechnology Introduction 11.20.4 Endo International Revenue in Nanobiotechnology Business (2016-2021) 11.20.5 Endo International Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Nanobiotechnology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Nanomedicine Table 3. Key Players of Nano Medical Devices Table 4. Key Players of Nano Diagnosis Table 5. Key Players of Other Table 6. Global Nanobiotechnology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Nanobiotechnology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Nanobiotechnology Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Nanobiotechnology Market Share by Regions (2016-2021) Table 10. Global Nanobiotechnology Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Nanobiotechnology Market Share by Regions (2022-2027) Table 12. Nanobiotechnology Market Trends Table 13. Nanobiotechnology Market Drivers Table 14. Nanobiotechnology Market Challenges Table 15. Nanobiotechnology Market Restraints Table 16. Global Nanobiotechnology Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Nanobiotechnology Market Share by Players (2016-2021) Table 18. Global Top Nanobiotechnology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanobiotechnology as of 2020) Table 19. Ranking of Global Top Nanobiotechnology Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Nanobiotechnology Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Nanobiotechnology Product Solution and Service Table 23. Date of Enter into Nanobiotechnology Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Nanobiotechnology Market Size by Type (2016-2021) (US$ Million) Table 26. Global Nanobiotechnology Revenue Market Share by Type (2016-2021) Table 27. Global Nanobiotechnology Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Nanobiotechnology Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Nanobiotechnology Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Nanobiotechnology Revenue Market Share by Application (2016-2021) Table 31. Global Nanobiotechnology Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Nanobiotechnology Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Nanobiotechnology Market Size by Type (2016-2021) (US$ Million) Table 34. North America Nanobiotechnology Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Nanobiotechnology Market Size by Application (2016-2021) (US$ Million) Table 36. North America Nanobiotechnology Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Nanobiotechnology Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Nanobiotechnology Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Nanobiotechnology Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Nanobiotechnology Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Nanobiotechnology Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Nanobiotechnology Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Nanobiotechnology Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Nanobiotechnology Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Nanobiotechnology Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Nanobiotechnology Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Nanobiotechnology Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Nanobiotechnology Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Nanobiotechnology Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Nanobiotechnology Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Nanobiotechnology Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Nanobiotechnology Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Nanobiotechnology Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Nanobiotechnology Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Nanobiotechnology Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Nanobiotechnology Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Nanobiotechnology Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Nanobiotechnology Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Nanobiotechnology Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Nanobiotechnology Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Nanobiotechnology Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Nanobiotechnology Market Size by Country (2022-2027) & (US$ Million) Table 63. Amgen Company Details Table 64. Amgen Business Overview Table 65. Amgen Nanobiotechnology Product Table 66. Amgen Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 67. Amgen Recent Development Table 68. Teva Pharmaceuticals Company Details Table 69. Teva Pharmaceuticals Business Overview Table 70. Teva Pharmaceuticals Nanobiotechnology Product Table 71. Teva Pharmaceuticals Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 72. Teva Pharmaceuticals Recent Development Table 73. Abbott Company Details Table 74. Abbott Business Overview Table 75. Abbott Nanobiotechnology Product Table 76. Abbott Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 77. Abbott Recent Development Table 78. UCB Company Details Table 79. UCB Business Overview Table 80. UCB Nanobiotechnology Product Table 81. UCB Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 82. UCB Recent Development Table 83. Roche Company Details Table 84. Roche Business Overview Table 85. Roche Nanobiotechnology Product Table 86. Roche Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 87. Roche Recent Development Table 88. Celgene Company Details Table 89. Celgene Business Overview Table 90. Celgene Nanobiotechnology Product Table 91. Celgene Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 92. Celgene Recent Development Table 93. Sanofi Company Details Table 94. Sanofi Business Overview Table 95. Sanofi Nanobiotechnology Product Table 96. Sanofi Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 97. Sanofi Recent Development Table 98. Merck & Co Company Details Table 99. Merck & Co Business Overview Table 100. Merck & Co Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 101. Merck & Co Recent Development Table 102. Biogen Company Details Table 103. Biogen Business Overview Table 104. Biogen Nanobiotechnology Product Table 105. Biogen Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 106. Biogen Recent Development Table 107. Stryker Company Details Table 108. Stryker Business Overview Table 109. Stryker Nanobiotechnology Product Table 110. Stryker Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 111. Stryker Recent Development Table 112. Gilead Sciences Company Details Table 113. Gilead Sciences Business Overview Table 114. Gilead Sciences Nanobiotechnology Product Table 115. Gilead Sciences Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 116. Gilead Sciences Recent Development Table 117. Pfizer Company Details Table 118. Pfizer Business Overview Table 119. Pfizer Nanobiotechnology Product Table 120. Pfizer Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 121. Pfizer Recent Development Table 122. 3M Company Company Details Table 123. 3M Company Business Overview Table 124. 3M Company Nanobiotechnology Product Table 125. 3M Company Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 126. 3M Company Recent Development Table 127. Johnson & Johnson Company Details Table 128. Johnson & Johnson Business Overview Table 129. Johnson & Johnson Nanobiotechnology Product Table 130. Johnson & Johnson Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 131. Johnson & Johnson Recent Development Table 132. Smith & Nephew Company Details Table 133. Smith & Nephew Business Overview Table 134. Smith & Nephew Nanobiotechnology Product Table 135. Smith & Nephew Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 136. Smith & Nephew Recent Development Table 137. Leadiant Biosciences Company Details Table 138. Leadiant Biosciences Business Overview Table 139. Leadiant Biosciences Nanobiotechnology Product Table 140. Leadiant Biosciences Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 141. Leadiant Biosciences Recent Development Table 142. Kyowa Hakko Kirin Company Details Table 143. Kyowa Hakko Kirin Business Overview Table 144. Kyowa Hakko Kirin Nanobiotechnology Product Table 145. Kyowa Hakko Kirin Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 146. Kyowa Hakko Kirin Recent Development Table 147. Shire Company Details Table 148. Shire Business Overview Table 149. Shire Nanobiotechnology Product Table 150. Shire Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 151. Shire Recent Development Table 152. Ipsen Company Details Table 153. Ipsen Business Overview Table 154. Ipsen Nanobiotechnology Product Table 155. Ipsen Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 156. Ipsen Recent Development Table 157. Endo International Company Details Table 158. Endo International Business Overview Table 159. Endo International Nanobiotechnology Product Table 160. Endo International Revenue in Nanobiotechnology Business (2016-2021) & (US$ Million) Table 161. Endo International Recent Development Table 162. Research Programs/Design for This Report Table 163. Key Data Information from Secondary Sources Table 164. Key Data Information from Primary Sources List of Figures Figure 1. Global Nanobiotechnology Market Share by Type: 2020 VS 2027 Figure 2. Nanomedicine Features Figure 3. Nano Medical Devices Features Figure 4. Nano Diagnosis Features Figure 5. Other Features Figure 6. Global Nanobiotechnology Market Share by Application: 2020 VS 2027 Figure 7. Anticancer Case Studies Figure 8. CNS Product Case Studies Figure 9. Anti-infective Case Studies Figure 10. Other Case Studies Figure 11. Nanobiotechnology Report Years Considered Figure 12. Global Nanobiotechnology Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Nanobiotechnology Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Nanobiotechnology Market Share by Regions: 2020 VS 2027 Figure 15. Global Nanobiotechnology Market Share by Regions (2022-2027) Figure 16. Global Nanobiotechnology Market Share by Players in 2020 Figure 17. Global Top Nanobiotechnology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanobiotechnology as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Nanobiotechnology Revenue in 2020 Figure 19. Global Nanobiotechnology Revenue Market Share by Type (2016-2021) Figure 20. Global Nanobiotechnology Revenue Market Share by Type (2022-2027) Figure 21. North America Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Nanobiotechnology Market Share by Type (2016-2027) Figure 23. North America Nanobiotechnology Market Share by Application (2016-2027) Figure 24. North America Nanobiotechnology Market Share by Country (2016-2027) Figure 25. United States Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Nanobiotechnology Market Share by Type (2016-2027) Figure 29. Europe Nanobiotechnology Market Share by Application (2016-2027) Figure 30. Europe Nanobiotechnology Market Share by Country (2016-2027) Figure 31. Germany Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Nanobiotechnology Market Share by Type (2016-2027) Figure 39. Asia-Pacific Nanobiotechnology Market Share by Application (2016-2027) Figure 40. Asia-Pacific Nanobiotechnology Market Share by Region (2016-2027) Figure 41. China Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Nanobiotechnology Market Share by Type (2016-2027) Figure 49. Latin America Nanobiotechnology Market Share by Application (2016-2027) Figure 50. Latin America Nanobiotechnology Market Share by Country (2016-2027) Figure 51. Mexico Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Nanobiotechnology Market Share by Type (2016-2027) Figure 55. Middle East & Africa Nanobiotechnology Market Share by Application (2016-2027) Figure 56. Middle East & Africa Nanobiotechnology Market Share by Country (2016-2027) Figure 57. Turkey Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Nanobiotechnology Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Amgen Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 61. Teva Pharmaceuticals Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 62. Abbott Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 63. UCB Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 64. Roche Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 65. Celgene Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 66. Sanofi Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 67. Merck & Co Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 68. Biogen Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 69. Stryker Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 70. Gilead Sciences Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 71. Pfizer Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 72. 3M Company Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 73. Johnson & Johnson Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 74. Smith & Nephew Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 75. Leadiant Biosciences Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 76. Kyowa Hakko Kirin Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 77. Shire Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 78. Ipsen Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 79. Endo International Revenue Growth Rate in Nanobiotechnology Business (2016-2021) Figure 80. Bottom-up and Top-down Approaches for This Report Figure 81. Data Triangulation Figure 82. Key Executives Interviewed

Amgen Teva Pharmaceuticals Abbott UCB Roche Celgene Sanofi Merck & Co Biogen Stryker Gilead Sciences Pfizer 3M Company Johnson & Johnson Smith & Nephew Leadiant Biosciences Kyowa Hakko Kirin Shire Ipsen Endo International